Medfinder
Back to blog

Updated: January 13, 2026

Molnupiravir Drug Interactions: What to Avoid and What to Tell Your Doctor

Author

Peter Daggett

Peter Daggett

Two medication bottles with drug interaction caution symbol

Good news: molnupiravir (Lagevrio) has no known drug-drug interactions. But there are still important precautions patients should understand before taking it.

When comparing COVID-19 antivirals, drug interactions are one of the most important factors. Paxlovid (nirmatrelvir/ritonavir) has dozens of clinically significant drug-drug interactions — with blood thinners, statins, immunosuppressants, seizure medications, and many others. This makes it unusable for a significant portion of high-risk patients.

Molnupiravir (Lagevrio) has a major advantage here: as of 2026, no clinically significant drug-drug interactions have been identified. But this doesn't mean there are zero precautions to take. Here's everything you need to know.

Does Molnupiravir Have Any Drug Interactions?

According to the FDA EUA Fact Sheet, the NIH COVID-19 Treatment Guidelines, and the current molnupiravir prescribing information: no drug-drug interactions have been identified for molnupiravir. Multiple independent drug reference sources — including Medscape, RxList, WebMD, and the Liverpool COVID Drug Interactions database — confirm that molnupiravir has no known severe, serious, or moderate drug-drug interactions.

This is because molnupiravir is not metabolized by the same CYP450 liver enzyme pathways that cause the extensive Paxlovid interaction profile. Molnupiravir is primarily cleared through metabolism to uridine and cytidine — which are normal nucleotides that mix into the body's existing nucleotide pools — and through renal and hepatic clearance.

Why Molnupiravir's Lack of Interactions Matters Clinically

For patients who need COVID-19 antiviral treatment but cannot take Paxlovid due to drug interactions, molnupiravir is often the only viable oral alternative. This patient population includes people taking:

Blood thinners like warfarin or apixaban (Eliquis)

Statins (some cannot be temporarily held, or holding them poses risk)

Immunosuppressants like tacrolimus, cyclosporine, or mycophenolate (transplant patients)

HIV medications (certain antiretrovirals)

Seizure medications (carbamazepine, phenytoin, phenobarbital)

Psychiatric medications that interact with CYP3A4

For all these patients, molnupiravir can be prescribed without the need to adjust, hold, or monitor for interactions with their existing medications.

What About Alcohol and Molnupiravir?

There is no known pharmacological interaction between alcohol and molnupiravir. However, heavy alcohol use is not recommended while you're fighting a COVID-19 infection because:

Alcohol can suppress immune function and slow your body's ability to fight infection.

Dizziness is a known side effect of molnupiravir; alcohol can worsen dizziness.

Alcohol can cause dehydration, which makes COVID-19 symptoms worse.

What About Food Interactions?

No food-drug interactions have been identified for molnupiravir. Food affects the rate (how quickly) of absorption but not the extent (how much is absorbed). This means you can take molnupiravir with or without food. If you experience nausea, taking it with food may help reduce stomach discomfort.

The Key Precaution: Pregnancy and Reproductive Safety

While molnupiravir has no drug-drug interactions, it does carry a significant reproductive safety warning:

Pregnancy: Molnupiravir is NOT recommended in pregnancy. Animal studies showed embryo-fetal lethality and birth defects. A boxed warning is included in the prescribing information.

Females of childbearing potential: Use reliable contraception during treatment and for 4 days after the last dose.

Males with female partners who could become pregnant: Use reliable contraception during treatment and for at least 3 months after the last dose (due to theoretical risk of NHC-TP effects on sperm).

Breastfeeding: Do not breastfeed during treatment or for 4 days after the last dose. Animal studies showed NHC was detected in nursing pup plasma.

Should You Still Tell Your Doctor All Your Medications?

Absolutely. Even though no drug-drug interactions are currently known for molnupiravir, the absence of identified interactions doesn't mean none could exist — only that none have been found in the studies conducted so far. Always provide your complete medication list, including over-the-counter medications, supplements, vitamins, and herbal products, to your prescriber before starting any new medication.

Molnupiravir vs. Paxlovid: Why the Interaction Profile Matters

If your doctor prescribed molnupiravir instead of Paxlovid, the reason is almost certainly drug interactions. Paxlovid contains ritonavir, a powerful CYP3A4 inhibitor that interacts with dozens of medications. For patients on multiple medications who need an oral COVID antiviral, molnupiravir is often the only option. Read our alternatives to molnupiravir guide to understand the full landscape of options.

Once your provider has prescribed molnupiravir, use medfinder to locate a pharmacy near you that has it in stock — so you can start treatment as quickly as possible.

Frequently Asked Questions

No known interaction between molnupiravir and warfarin or other blood thinners has been identified. This is a significant advantage over Paxlovid, which requires close INR monitoring and dose adjustments when used with warfarin. However, always inform your provider about all medications you take.

As of 2026, no drug-drug interactions have been identified between molnupiravir and common heart or blood pressure medications. This contrasts with Paxlovid, which interacts with many cardiac medications. Discuss your complete medication list with your provider before starting any antiviral.

No known interactions between molnupiravir and immunosuppressants like tacrolimus or mycophenolate have been reported. This makes molnupiravir a particularly important option for organ transplant recipients who often cannot take Paxlovid due to these interactions.

Paxlovid contains ritonavir, a potent inhibitor of the CYP3A4 liver enzyme, which metabolizes many medications. When ritonavir blocks this enzyme, it causes blood levels of other drugs to rise dangerously. Molnupiravir is metabolized through a completely different pathway — converted to normal nucleosides — and does not inhibit CYP enzymes, resulting in no known drug-drug interactions.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Molnupiravir also looked for:

29,818 have already found their meds with Medfinder.

Start your search today.

29K+
5-star ratingTrusted by 29,818 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?